Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate

Clinical Conversations » Podcast Feed by NEJM Group

Patients with metastatic breast cancer whose tumors express low levels of HER2 are generally classified and treated as having HER2-negative disease. However, Dr. Shanu Modi of the Memorial Sloan Kettering Cancer Center a...View more